You can't compare DCC with GXY or RAP they are different beasts altogether.
GXY was undervalued and still is IMO. They have the value for the company in the ground and a commodity price and a demand to support it. And I have enjoyed and continue to enjoy the GXY ride.
RAP developed and own the IP that is used in their app, once the FDA approval is granted it will rocket again IMO. I bought into RAP during the dip last week.
DCC Price at posting:
14.0¢ Sentiment: Hold Disclosure: Held
